Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
04/2000
04/13/2000WO2000020562A1 A novel lymphocyte population expressing intracellular mo2
04/13/2000WO2000020554A1 Microfabricated cell injector
04/13/2000WO2000020459A1 Crystals of the alpha 1 beta 1 integrin i-domain and their use
04/13/2000WO2000020458A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage
04/13/2000WO2000020457A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation
04/13/2000WO2000020455A1 Novel g protein-coupled receptor protein and dna thereof
04/13/2000WO2000020454A1 Methods and materials for detection and measurement of free radical damage
04/13/2000WO2000020450A2 Calcium channel alpha-2/delta gene
04/13/2000WO2000020448A2 Nlk1 -interacting proteins
04/13/2000WO2000020447A2 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses
04/13/2000WO2000020446A2 Bax-mediated apoptosis modulating reagents and methods
04/13/2000WO2000020445A2 Tumor antigens and ctl clones isolated by a novel procedure
04/13/2000WO2000020443A1 Novel peptides
04/13/2000WO2000020438A1 G protein-coupled receptor resembling the thrombin receptor
04/13/2000WO2000020357A2 Chemical constructs
04/13/2000WO2000020044A1 A novel method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
04/13/2000WO2000020043A1 A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers
04/13/2000WO2000020041A2 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent
04/13/2000WO2000020039A1 Methods and adjuvants for stimulating mucosal immunity
04/13/2000WO2000020037A1 A novel component in the hedgehog signalling pathway
04/13/2000WO2000020032A1 RECOMBINANT CAT ALLERGEN, Fel dI, EXPRESSED IN BACULOVIRUS FOR DIAGNOSIS AND TREATMENT OF CAT ALLERGY
04/13/2000WO2000020031A1 Methods for identification, diagnosis, and treatment of breast cancer
04/13/2000WO2000020029A1 Genes differentially expressed in cancer cells to design cancer vaccines
04/13/2000WO2000020026A2 Compositions and methods for inhibiting angiogenesis
04/13/2000WO2000020025A2 Akt compositions for enhancing survival of cells
04/13/2000WO2000020020A2 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease
04/13/2000WO2000020011A1 Isolated dna encoding human h3 histamine receptor
04/13/2000WO2000020007A1 Method and compositions for increasing bone mass
04/13/2000WO2000019993A2 Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells
04/13/2000WO2000019988A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
04/13/2000WO2000019883A2 Compositions and methods of disease diagnosis and therapy
04/13/2000WO2000019823A1 Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof
04/13/2000WO2000003242A3 Solid solventless protein assay with standards
04/13/2000WO2000003241A3 Method and device for determining the base number (bn) of a lubricating oil
04/13/2000WO2000003015A3 Human transport protein homologs
04/13/2000WO2000001408A3 Haemophilus parasuis vaccine and diagnostic
04/13/2000WO2000000137A3 Disposable article having bodily waste isolation device
04/13/2000WO1999065924A3 Preparation and use of superior vaccines
04/13/2000WO1999063094A3 Nucleotide and protein sequences of gpr1 and methods based thereon
04/13/2000WO1999053288A3 Systems and methods for interpreting immunoblot test results
04/13/2000WO1999051265A9 Nucleic acid encoding hyaluronan synthase and methods of use
04/13/2000WO1999050637A3 Isolated multimeric complexes useful in analysis of t cells, peptides useful in making the complexes, and uses thereof
04/13/2000WO1999045387A3 Electrochemical analyte sensor
04/13/2000WO1999045386A8 Method for performing blood cell counts
04/13/2000DE19852800C1 Production of antibodies to a polypeptide encoded by a known DNA sequence comprises binding of antibodies produced by DNA vaccination to immobilized recombinantly expressed polypeptide
04/13/2000DE19846271A1 Immunoassay for enteroviral antigens useful for diagnosis, comprises binding the antigens to one or more immobilized capture antibodies directed against enterovirus group-specific determinants
04/13/2000DE19845075A1 Verfahren zum Herstellen eines Bauelementes und Bauelement A method for producing a component and component
04/13/2000DE19844988A1 Parallele Festphasensynthese Parallel solid phase synthesis
04/13/2000DE19842998A1 Process for testing soil samples comprises using a container having a flat resonating base
04/13/2000CA2354863A1 Prevention of adhesions
04/13/2000CA2354544A1 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant gpiiia and/or variant gpiib allele
04/13/2000CA2347120A1 Nlk1 -interacting proteins
04/13/2000CA2346765A1 Compositions and methods of disease diagnosis and therapy
04/13/2000CA2346695A1 Methods of screening for apoptosis-controlling agents for bone anabolic therapies and uses thereof
04/13/2000CA2346496A1 Novel th2-specific molecules and uses thereof
04/13/2000CA2346459A1 In vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction
04/13/2000CA2346456A1 Method and compositions for increasing bone mass
04/13/2000CA2346452A1 Methods and adjuvants for stimulating mucosal immunity
04/13/2000CA2346339A1 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with rage
04/13/2000CA2346326A1 A novel method of diagnosing, monitoring, staging and treating gynecological and prostatic cancers
04/13/2000CA2346217A1 Extracellular novel rage binding protein (en-rage) and uses thereof
04/13/2000CA2346134A1 G protein-coupled receptor resembling the thrombin receptor
04/13/2000CA2346124A1 Immunodiagnosis of polyneuropathies using heparan sulfate glycosaminoglycan
04/13/2000CA2346070A1 Bax-mediated apoptosis modulating reagents and methods
04/13/2000CA2346068A1 A novel lymphocyte population expressing intracellular mo2
04/13/2000CA2346048A1 Methods for identification, diagnosis, and treatment of breast cancer
04/13/2000CA2345881A1 Bone marrow-derived serum proteins
04/13/2000CA2345663A1 Screen for risk for gastric adenocarcinoma
04/13/2000CA2345615A1 Novel g protein-coupled receptor protein and dna thereof
04/13/2000CA2345477A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation
04/13/2000CA2345440A1 Genes differentially expressed in cancer cells to design cancer vaccines
04/13/2000CA2345408A1 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent
04/13/2000CA2345377A1 Novel secreted proteins and polynucleotides encoding them
04/13/2000CA2345372A1 Biochip and biochip reading device comprising a plurality of zones for molecular recognition
04/13/2000CA2345285A1 A novel method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers
04/13/2000CA2345023A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock
04/13/2000CA2345000A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers
04/13/2000CA2344995A1 Cancer associated antigens and uses therefor
04/13/2000CA2344973A1 Oxidoreductase molecules
04/13/2000CA2344623A1 Method to determine a predisposition to leptin treatment
04/13/2000CA2344613A1 Compositions and methods for inhibiting angiogenesis
04/13/2000CA2344563A1 Methods and compositions for the diagnosis and therapy of prostate cancer
04/13/2000CA2344551A1 P-conotoxin peptide
04/13/2000CA2343651A1 Use of socs-2 or cis to screen for compounds enhancing growth hormone effect
04/13/2000CA2342606A1 Thromboplastin reagents and methods for preparing and using such reagents
04/13/2000CA2341351A1 Alpha-2/delta gene
04/13/2000CA2340333A1 Crystals of the alpha 1 beta 1 integrin i-domain and their use
04/13/2000CA2338796A1 Assay using porosity-reduction to inhibit migration
04/13/2000CA2335391A1 Akt compositions for enhancing survival of cells
04/13/2000CA2281159A1 Spectrophotometric apparatus with multiple readheads
04/12/2000EP0992795A1 Improved method for the detection of creatinine
04/12/2000EP0992794A2 Enzyme-antibody complex and a method for manufacturing the same
04/12/2000EP0992793A2 Screening organic compounds for cognitive function modulating activity
04/12/2000EP0992792A2 Fluid analyte measurement system
04/12/2000EP0992791A2 Method and apparatus for measuring moisture in wall materials with signal analysing
04/12/2000EP0992589A2 Glucose sensor
04/12/2000EP0992584A2 Purified mammalian FLT3 ligands and agonists and antagonists thereof
04/12/2000EP0992578A1 Methods for labeling intracytoplasmic molecules
04/12/2000EP0992512A2 Reduced cortisol conjugate
04/12/2000EP0991948A1 Detection and determination of phenol-like substances by means of direct wet-chemical methods
1 ... 3125 3126 3127 3128 3129 3130 3131 3132 3133 3134 3135 3136 3137 3138 3139 3140 3141 3142 3143 3144 3145 ... 3937